Skip to main content
. 2020 Jul 31;10(8):504. doi: 10.3390/brainsci10080504

Figure 4.

Figure 4

IPA m/z Range MS/MS Serum Data Analysis for Epilepsy Patients vs. Controls using top 100 Peptide/Proteins from Table 3 and Table 4. Ingenuity Pathway Analysis (IPA), (Qiagen, Inc.) of the 100 peptides/proteins exhibited in Table 3 and Table 4 having a 2× difference in positive sera number between epilepsy and controls, and a 1.5× difference in MS/MS “hit” (single peptide identification) ratio between the two groups. The protein function legend is at the bottom of the figure.